Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Restricted Stock Units

	For the Year Ended December 31,
	2024					2023
	Number of Shares			Weighted-Average Grant Date Fair Value Per Share		Number of Shares			Weighted-Average Grant Date Fair Value Per Share
Unvested balance at January 1		954,306		$	4.39		160,000		$	12.08
RSUs granted		946,432		$	0.53		870,200		$	3.46
RSUs vested		(1,768,443	)	$	2.31		(44,680	)	$	13.11
RSUs forfeited		(42,464	)	$	2.75		(31,214	)	$	5.28
Unvested balance at December 31		89,831		$	5.51		954,306		$	4.39

Schedule of Option Activity

A summary of option activity for the years ended December 31, 2024 and 2023 is presented below.

	Number of Shares		Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value
Outstanding at December 31, 2022		7,332	$	28.50		8.3		-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at December 31, 2023		7,332	$	28.50		7.3		-
Granted		-		-		-		-
Exercised		-		-		-		-
Forfeited or expired		-		-		-		-
Outstanding at December 31, 2024		7,332	$	28.50		6.3		-
Vested or expected to vest at December 31, 2024		7,332	$	28.50		6.3		-
Exercisable at December 31, 2024		7,332	$	28.50		6.3		-

Schedule of Share-based compensation expense

	For the Year Ended December 31,
	2024		2023
Selling, general and administrative expenses	$	2,728,852	$	875,509
Research and development expenses		805,217		220,723
Cost of revenues		9,032		18,535
Total	$	3,543,101	$	1,114,767